Riskpilot← Back to searchSign inGet full accessCELLTECH AS
ASActiveOrg 916201796Bjørnerudveien 12C, 1266 OsloWholesale of other machinery and equipment · NACE 4664Est. 195913 employees
Revenue 2025
NOK 60,4M
-10% vs 2024
EBITDA margin
4.8%
-2% vs 2024
Equity ratio
27.0%
Financial strength
Net profit 2025
NOK 2,2M
0% vs 2024
| Revenue | NOK 60,4M | -10% |
| EBITDA | NOK 2,9M | -2% |
| Net profit | NOK 2,2M | +0% |
| Total assets | NOK 22,5M | -1% |
| Equity | NOK 6,1M | +6% |
| Employees | 13 | — |
Legal name
CELLTECH AS
Org number
916201796
Legal form
Aksjeselskap
NACE code
4664 · Wholesale of other machinery and equipment
Founded
3. januar 1959
Share capital
NOK 449 600
Employees
13 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap.
Address
Bjørnerudveien 12C, 1266 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 49 403 | 48 682 | 45 442 | 67 159 | 60 415 |
| Staff expenses | −10 951 | −9 989 | −7 136 | −14 314 | −14 523 |
| EBITDA | 1 601 | 3 275 | 5 240 | 2 973 | 2 902 |
| Depreciation & amort. | −156 | −166 | −146 | −128 | −112 |
| EBIT | 1 445 | 3 109 | 5 093 | 2 845 | 2 790 |
| Net financials | −640 | −16 | 151 | 19 | 70 |
| Profit before tax | 805 | 3 093 | 5 244 | 2 864 | 2 860 |
| Tax | 177 | 684 | 1 160 | 630 | 630 |
| Net profit | 628 | 2 409 | 4 084 | 2 234 | 2 230 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 14 439 | 18 018 | 16 178 | 22 779 | 22 505 |
| Equity | 5 448 | 4 516 | 3 945 | 5 723 | 6 081 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 8 991 | 13 502 | 12 233 | 17 056 | 16 424 |
| Total debt | 8 991 | 13 502 | 12 233 | 17 056 | 16 424 |
EBITDA margin
4.8%
This company
15.8%
Market median
-70% vs market
20212025
Equity ratio
27.0%
This company
38.2%
Market median
-29% vs market
20212025
Return on equity
36.7%
This company
18.4%
Market median
+99% vs market
20212025
Net profit margin
3.7%
This company
8.1%
Market median
-54% vs market
20212025
Asset turnover
2.68×
This company
1.12×
Market median
+139% vs market
20212025
Debt / equity
2.70×
This company
0.62×
Market median
-335% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-04-01 – 2021-03-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
HM Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2025 | |
| Former (3) | ||
| Board of Directors | 2020 – 2021 | |
| Chairman | 2021 – 2025 | |
| Board of Directors | 2021 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2022 | |
Addtech Nordic Ab | Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of CELLTECH AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Halvor Moe Bjørnstad | Chief Executive Officer | 0 companies |
| Per Erik Tomas Pehrsson | Board of Directors | 0 companies |
| Peter Carl Mikael Andersson | Chairman | 0 companies |
| Kim Kristian Nikitin | Chairman | 0 companies |
| Joseph Chang-Hsin Kan | Board of Directors | 0 companies |